9.36
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AVXL Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$9.51
Aprire:
$9.585
Volume 24 ore:
844.34K
Relative Volume:
0.85
Capitalizzazione di mercato:
$803.97M
Reddito:
-
Utile/perdita netta:
$-48.17M
Rapporto P/E:
-16.42
EPS:
-0.57
Flusso di cassa netto:
$-37.10M
1 W Prestazione:
+1.52%
1M Prestazione:
-13.49%
6M Prestazione:
+11.30%
1 anno Prestazione:
+66.55%
Anavex Life Sciences Corporation Stock (AVXL) Company Profile
Nome
Anavex Life Sciences Corporation
Settore
Industria
Telefono
844-689-3939
Indirizzo
630 5TH AVENUE, NEW YORK
Confronta AVXL con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
AVXL
Anavex Life Sciences Corporation
|
9.36 | 814.27M | 0 | -48.17M | -37.10M | -0.57 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Anavex Life Sciences Corporation Stock (AVXL) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2022-12-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
2022-06-23 | Iniziato | Berenberg | Buy |
2021-09-23 | Iniziato | BTIG Research | Buy |
2020-12-16 | Reiterato | H.C. Wainwright | Buy |
2020-09-28 | Iniziato | Ladenburg Thalmann | Buy |
2020-02-27 | Iniziato | Cantor Fitzgerald | Overweight |
2019-06-18 | Iniziato | Janney | Buy |
2018-05-16 | Ripresa | Maxim Group | Buy |
2018-03-08 | Iniziato | ROTH Capital | Buy |
2018-02-13 | Reiterato | Maxim Group | Buy |
2017-09-29 | Ripresa | Noble Financial | Buy |
2017-02-07 | Iniziato | Noble Financial | Buy |
2016-03-29 | Iniziato | FBR Capital | Outperform |
Mostra tutto
Anavex Life Sciences Corporation Borsa (AVXL) Ultime notizie
Sentiment analysis tools applied to Anavex Life Sciences Corp.Bond Market & Weekly Momentum Stock Picks - Newser
Has Anavex Life Sciences Corp. found a price floorWeekly Stock Report & Real-Time Sentiment Analysis - Newser
Is Anavex Life Sciences Corp. stock poised for growthGlobal Markets & Daily Chart Pattern Signal Reports - Newser
Multi asset correlation models including Anavex Life Sciences Corp.2025 Bull vs Bear & Short-Term Trading Alerts - Newser
Anavex Life Sciences Corp. stock outlook for YEAR2025 Earnings Impact & High Conviction Trade Alerts - Newser
Statistical indicators supporting Anavex Life Sciences Corp.’s strength2025 Support & Resistance & Daily Oversold Bounce Ideas - Newser
What’s the beta of Anavex Life Sciences Corp. stockJuly 2025 Price Swings & Weekly Chart Analysis and Trade Guides - khodrobank.com
Anavex Life Sciences Corp. stock volume spike explainedJuly 2025 Fed Impact & High Yield Stock Recommendations - Newser
Is this a good reentry point in Anavex Life Sciences Corp.2025 Volatility Report & Low Drawdown Trading Techniques - Newser
Using R and stats models for Anavex Life Sciences Corp. forecasting2025 Short Interest & Advanced Swing Trade Entry Plans - Newser
Using data models to predict Anavex Life Sciences Corp. stock movementJuly 2025 Recap & Weekly Market Pulse Alerts - Newser
Using AI based signals to follow Anavex Life Sciences Corp.Weekly Investment Report & Free Growth Oriented Trading Recommendations - Newser
What MACD signals say about Anavex Life Sciences Corp.Market Risk Report & Daily Stock Momentum Reports - Newser
Chart based analysis of Anavex Life Sciences Corp. trendsQuarterly Performance Summary & Weekly High Return Stock Opportunities - Newser
Published on: 2025-09-03 01:45:56 - Newser
Price momentum metrics for Anavex Life Sciences Corp. explained2025 Bull vs Bear & Expert-Curated Trade Recommendations - Newser
Can technical indicators confirm Anavex Life Sciences Corp.’s reversalMarket Sentiment Summary & Risk Controlled Stock Pick Alerts - Newser
Trend analysis for Anavex Life Sciences Corp. this weekQuarterly Profit Review & Community Verified Watchlist Alerts - Newser
Using data tools to time your Anavex Life Sciences Corp. exitWeekly Trend Report & Capital Efficiency Focused Strategies - Newser
Anavex Life Sciences Corp. stock trend forecastJuly 2025 Trends & Intraday High Probability Alerts - Newser
Using Bollinger Bands to evaluate Anavex Life Sciences Corp.July 2025 Analyst Calls & Free Fast Gain Swing Trade Alerts - Newser
Sector ETF performance correlation with Anavex Life Sciences Corp.2025 Price Action Summary & Weekly Consistent Profit Watchlists - Newser
Why is Anavex Life Sciences Corp. stock going downJuly 2025 PostEarnings & Risk Managed Trade Strategies - khodrobank.com
Levi & Korsinsky Reminds Anavex Life Sciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024AVXL - ACCESS Newswire
What does recent volatility data suggest for Anavex Life Sciences Corp.Portfolio Risk Summary & Safe Entry Trade Signal Reports - Newser
How to track smart money flows in Anavex Life Sciences Corp.Inflation Watch & Free Expert Verified Stock Movement Alerts - Newser
Anavex Life Sciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference 2025 - The Manila Times
CNS Drug Developer Anavex Life Sciences to Showcase Pipeline at Major Investment Conference - Stock Titan
Can Anavex Life Sciences Corp. lead its sector in growthJuly 2025 Setups & Growth Oriented Trade Recommendations - khodrobank.com
How institutional ownership impacts Anavex Life Sciences Corp. stockMarket Trend Review & Consistent Profit Trading Strategies - Newser
How cyclical is Anavex Life Sciences Corp.’s revenue streamQuarterly Risk Review & Verified Short-Term Trading Plans - khodrobank.com
Price Floor Holding on Anavex Life Sciences Corp. — Rebound Possible getLinesFromResByArray error: size == 0 - kangso.co.kr
Is Anavex Life Sciences Corp.’s growth already priced inChart Signals & Growth Focused Stock Pick Reports - khodrobank.com
Published on: 2025-09-02 01:15:53 - khodrobank.com
Will Anavex Life Sciences Corp. benefit from rate cuts2025 Dividend Review & Free Long-Term Investment Growth Plans - khodrobank.com
Sentiment analysis tools applied to Anavex Life Sciences Corp2025 Fundamental Recap & Weekly Momentum Stock Picks - Newser
Anavex Life Sciences Corp. stock trendline breakdown2025 Growth vs Value & Long-Term Growth Stock Strategies - Newser
Order flow analysis tools used on Anavex Life Sciences Corp.Trade Analysis Summary & Safe Entry Trade Reports - Newser
Why Anavex Life Sciences Corp. is moving todayEarnings Risk Summary & Real-Time Volume Spike Alerts - Newser
Anavex Life Sciences Corporation Azioni (AVXL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Anavex Life Sciences Corporation Azioni (AVXL) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
MISSLING CHRISTOPHER U | President and CEO |
Mar 24 '25 |
Option Exercise |
0.92 |
500,000 |
460,000 |
1,750,210 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):